Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Published:2005-04-14 Issue:7035 Volume:434 Page:913-917
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Bryant Helen E.,Schultz Niklas,Thomas Huw D.,Parker Kayan M.,Flower Dan,Lopez Elena,Kyle Suzanne,Meuth Mark,Curtin Nicola J.,Helleday Thomas

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature03443.pdf

Reference26 articles.

1. Lindahl, T., Satoh, M. S., Poirier, G. G. & Klungland, A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 20, 405–411 (1995)

2. D'Amours, D., Desnoyers, S., D'Silva, I. & Poirier, G. G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342, 249–268 (1999)

3. El-Khamisy, S. F., Masutani, M., Suzuki, H. & Caldecott, K. W. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 31, 5526–5533 (2003)

4. Conde, C. et al. Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice. EMBO J. 20, 3535–3543 (2001)

5. de Murcia, J. M. et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl Acad. Sci. USA 94, 7303–7307 (1997)

Cited by 4223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous inhibition of ATM, ATR, and DNA-PK causes synergistic lethality;Biochemical and Biophysical Research Communications;2024-12

2. Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approaches;Translational Oncology;2024-12

3. Carbamoylation at C-8 position of natural 3-arylcoumarin scaffold for the discovery of novel PARP-1 inhibitors with potent anticancer activity;European Journal of Medicinal Chemistry;2024-11

4. Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Polθ inhibition;Radiotherapy and Oncology;2024-11

5. DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors;British Journal of Cancer;2024-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3